Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fospropofol vs propofol for postoperative nausea and vomiting in high-risk gynecologic laparoscopy
ChiCTR2500114542Phase 4Not yet recruiting
- Sponsor
- Obstetrics and Gynecology Hospital of Fudan University
- Start
- Dec 2025
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative nausea and vomiting (PONV) comparing Propofol group with Fospropofol group (2 arms). Primary endpoint: Incidence of nausea and vomiting 6 hours after surgery. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
fospropofol disodiumpropofol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500114542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500114542.